Grey Wolf Animal Health Corp. (TSXV:WOLF)

Market Cap	51.29M +166.6%
Revenue (ttm)	33.47M +27.3%
Net Income	826.35K -10.4%
EPS	0.02 -21.6%
Shares Out	34.19M
PE Ratio	64.41
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	37,075
Average Volume	34,010
Open	1.420
Previous Close	1.310
Day's Range	1.410 - 1.510
52-Week Range	0.800 - 1.510
Beta	0.52
RSI	59.90
Earnings Date	Apr 10, 2026

About Grey Wolf Animal Health

Grey Wolf Animal Health Corp. operates as an animal health and wellness company in Canada. The company operates in two segments, Animal Health Business Unit and Pharmacy Business Unit. It engages in the sale, marketing, and distribution of pharmaceutical, nutraceutical, and consumable products to veterinary clinics, as well as offers pharmaceuticals for the human and animal health markets. The company provides dexmedetomidine hydrochloride oromucosal gel under the SILEO name; sedative analgesic and reversing agents for companion animals under t...

• Industry: Personal Services
• Sector: Consumer Discretionary
• CEO: Angela Cechetto
• Country: Canada
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: WOLF

Financial Performance

In 2024, Grey Wolf Animal Health's revenue was 26.83 million, an increase of 5.58% compared to the previous year's 25.41 million. Earnings were 704,668, an increase of 15.60%.